|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Number of the document | 2178916 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08796917.6 |
| Date of filing the European patent application | 2008-07-31 | |
| (97) | Date of publication of the European application | 2010-04-28 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/071709 |
| Date | 2008-07-31 |
| (87) | Number | WO 2009/018411 |
| Date | 2009-02-05 |
| (30) | Number | Date | Country code |
| 962811 P | 2007-07-31 | US | |
| 67994 P | 2008-03-03 | US |
| (72) |
MARTIN, Joel, H., US
WANG, Li-Hsien, US
STEVENS, Sean, US
ALLISON, Erin, M., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | HUMAN ANTIBODIES TO HUMAN CD20 AND METHOD OF USING THEREOF |
| HUMAN ANTIBODIES TO HUMAN CD20 AND METHOD OF USING THEREOF |